Home > Drugs A – Z > Fluocinonide (On the skin)

Fluocinonide (On the skin)

Treats many skin disorders. Also relieves pain, itching, and swelling caused by skin diseases. This medicine is a corticosteroid.

What works?

Learn more about the effects of these drugs. The most reliable research is summed up for you in our featured article.

Fluocinonide topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. This medicine is a corticosteroid (cortisone-like medicine or steroid). This medicine is available only with your doctor's prescription… Read more
Brand names include
Fluocinonide, Lidemol, Lidex, Lidex Mild, Lidex Regular, Lidex-E, Lyderm, Tcis, Tiamol, Topsyn, Trisyn, Vanos
Drug classes About this
Corticosteroid, Strong

What works? Research summarized

Evidence reviews

Drugs for discoid lupus erythematosus

Discoid lupus erythematosus (DLE) is a form of skin inflammation which occurs particularly on sun‐exposed skin and can cause scarring. All forms of cutaneous lupus erythematosus are most common in women of childbearing age, which is important because some treatments, including thalidomide and acitretin, can cause birth defects, and hydroxychloroquine may cause damage to the eye or ear. As the chronic nature and scarring of DLE can have psychological impact, and some treatments may produce serious adverse effects, we felt it was important to combat uncertainty and identify the best and safest treatment. The evidence is current to September 2016.

Psoriasis: Assessment and Management of Psoriasis

Psoriasis is a common, chronic disease, which for many people, is associated with profound functional, psychological and social morbidity and important comorbidities. Effective treatments are available. Some treatments are expensive; all require appropriate monitoring and some may only be accessed in specialist care settings. Evidence indicates that a substantial proportion of people with psoriasis are currently dissatisfied with their treatment.

End of Life Care for Infants, Children and Young People with Life-Limiting Conditions: Planning and Management

This guideline covers the physical, emotional, social and spiritual elements of end of life care, and focuses on improving the child or young person’s quality of life and supporting their family and carers. There are, for instance, recommendations on managing distressing symptoms and providing care and bereavement support after death. Recommendations have also been made about how services should be delivered. The guideline is aimed at all providers of paediatric end of life care, whatever their level of practise, and also for children and young people with life-limiting conditions and their parents or carers.

See all (8)

Summaries for consumers

Drugs for discoid lupus erythematosus

Discoid lupus erythematosus (DLE) is a form of skin inflammation which occurs particularly on sun‐exposed skin and can cause scarring. All forms of cutaneous lupus erythematosus are most common in women of childbearing age, which is important because some treatments, including thalidomide and acitretin, can cause birth defects, and hydroxychloroquine may cause damage to the eye or ear. As the chronic nature and scarring of DLE can have psychological impact, and some treatments may produce serious adverse effects, we felt it was important to combat uncertainty and identify the best and safest treatment. The evidence is current to September 2016.

PubMed Health Blog...

read all...